Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)

Clinical trial NCT07478991 · RECRUITING

Trial details

NCT number: NCT07478991
Sponsor: PETHEMA Foundation
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia, Adult

Start date: 2026-07-02
Primary completion: 2030-04-01
Enrollment: 376

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.